SCHEMBL329146

SCHEMBL329146

O=C(O)C(O)N(CCN(c1ccccc1)C(O)C(=O)O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.41
LMNA P02545 3/20 0.40
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAPK1 P28482 1/20 0.40
ALDH1A1 P00352 3/20 0.39
HTT P42858 2/20 0.39
NPC1 O15118 1/20 0.39
POLB P06746 1/20 0.39
RAB9A P51151 1/20 0.39
GLA P06280 1/20 0.39
TSHR P16473 1/20 0.39
TP53 P04637 2/20 0.39
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9283956 0.88 NPSR1 (0.41) NPSR1LMNAKMT2ASMN1; SMN2MEN1
SCHEMBL15015552 0.84 ALDH1A1 (0.50) NPSR1LMNAKMT2ASMN1; SMN2MEN1
SCHEMBL8597741 0.84 NPSR1 (0.39) NPSR1LMNAKMT2ASMN1; SMN2MAPK1
SCHEMBL2982521 0.82 HTR1A (0.44) KMT2AMEN1ALDH1A1TP53
SCHEMBL2978606 0.82 AKR1B1 (0.33) NPSR1LMNAKMT2ASMN1; SMN2MEN1
SCHEMBL2982522 0.82 HTR1A (0.44) KMT2AMEN1ALDH1A1TP53
SCHEMBL2978608 0.82 AKR1B1 (0.33) NPSR1LMNAKMT2ASMN1; SMN2MEN1
SCHEMBL2978165 0.77 EGFR (0.42) KMT2AMEN1CYP3A4CYP2C9CYP2C19
SCHEMBL2990073 0.77 TYR (0.45)
SCHEMBL2978168 0.77 EGFR (0.42) KMT2AMEN1CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 350 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8541344-B2 Compositions with cyclopropenes and metal-complexing agents ROHM AND HAAS COMPANY (US) 2013-09-24 US claimed
US-20090061052-A1 Casings for Foodstuffs RED ARROW PRODUCTS CO., LLC. (US) 2009-03-05 US claimed
EP-1011131-B1 Methods for enhancing the metal removal rate during the chemical-mechanical polishing process of a semiconductor INFINEON TECHNOLOGIES AG (DE) 2007-07-25 EP claimed
EP-1368042-A4 HAIR RELAXER SYSTEM AND METHOD THEREFOR AVLON IND INC (US) 2005-09-07 EP claimed
EP-1368042-A2 HAIR RELAXER SYSTEM AND METHOD THEREFOR AVLON INDUSTRIES INC. (US) 2003-12-10 EP claimed
US-6602493-B2 Prevention deposits of metal compound on hair; applying base, then removal with chelate compound AVLON INDUSTRIES, INC. 2003-08-05 US claimed
EP-0873106-B1 USE OF METALLOFLUOROCOMPLEXES FOR DENTAL COMPOSITIONS MINNESOTA MINING & MFG (US) 2003-05-02 EP claimed
US-20030049222-A1 Hair relaxer system and method therefor AVLON INDUSTRIES, INC., AN ILLINOIS CORPORATION 2003-03-13 US claimed
WO-2002065982-A2 HAIR RELAXER SYSTEM AND METHOD THEREFOR AVLON INDUSTRIES, INC. (US) 2002-08-29 WO claimed
US-6391286-B1 CURABLE DENTAL COMPOSITION COMPRISING PREFORMED METAL COMPLEX AS FLUORIDE RELEASING MATERIAL 3M INNOVATIVE PROPERTIES COMPANY 2002-05-21 US claimed
EP-0873106-A1 USE OF METALLOFLUOROCOMPLEXES FOR DENTAL COMPOSITIONS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1998-10-28 EP claimed
WO-1997018791-A1 USE OF METALLOFLUOROCOMPLEXES FOR DENTAL COMPOSITIONS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-05-29 WO claimed
EP-0386886-A1 Deicing compositions comprising calcium magnesium acetate and chelating agent GENERAL ATOMICS INTERNATIONAL SERVICES CORPORATION (US) 1990-09-12 EP claimed
US-4377625-A AMINOCARBOXYLIC ACID, POLYAMINE OR AMINOALCOHOL CHELATING AGENT DURACELL INC. (US) 1983-03-22 US claimed
EP-4629967-A1 PERFLUORINATED MICELLES AND MEDICAL USES THEREOF Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) 2025-10-15 EP disclosed
WO-2025080785-A1 METHODS AND MOLECULAR CONSTRUCTS FOR INCORPORATING MOLECULES INTO ELECTRICAL CIRCUITS ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2025-04-17 WO disclosed
US-20250041213-A1 STABLE SOLID FINGOLIMOD DOSAGE FORM HANDA NEUROSCIENCE, LLC (US) 2025-02-06 US disclosed
EP-0216531-A1 Use of immersion tin and tin alloys as a bonding medium for multilayer circuits TECHNO INSTRUMENTS INVESTMENTS 1983 LTD. (IL) 1987-04-01 EP disclosed
EP-0198765-A2 Preparation of liposomes GEORGETOWN UNIVERSITY (US) 1986-10-22 EP disclosed
US-4377625-A AMINOCARBOXYLIC ACID, POLYAMINE OR AMINOALCOHOL CHELATING AGENT DURACELL INC. (US) 1983-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250041213-A1 STABLE SOLID FINGOLIMOD DOSAGE FORM S1PR4, S1PR2, S1PR5 NPSR1 3331/4885LMNA 1708/4885KMT2A 232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.